Jung Keum Ji, Won Daeyoun, Jeon Christina, Kim Soriul, Kim Tae Il, Jee Sun Ha, Beaty Terri H
Department of Public Health, Graduate School, Yonsei University, Seoul, South Korea.
The Catholic University of Korea, Seoul Saint Mary's Hospital, Seoul, South Korea.
BMC Genet. 2015 May 9;16:49. doi: 10.1186/s12863-015-0207-y.
Genome-wide association studies have identified numerous single nucleotide polymorphisms (SNPs) as associated with colorectal cancer (CRC) risk in populations of European descent. However, their utility for predicting risk to CRC in Asians remains unknown. A case-cohort study (random sub-cohort N=1,685) from the Korean Cancer Prevention Study-II (KCPS-II) (N=145,842) was used. Twenty-three SNPs identified in previous 47 studies were genotyped on the KCPS-II sub-cohort members. A genetic risk score (GRS) was calculated by summing the number of risk alleles over all SNPs. Prediction models with or without GRS were evaluated in terms of the area under the receiver operating characteristic curve (AUROC) and the continuous net reclassification index (NRI).
Seven of 23 SNPs showed significant association with CRC and rectal cancer in Koreans, but not with colon cancer alone. AUROCs (95% CI) for traditional risk score (TRS) alone and TRS plus GRS were 0.73 (0.69-0.78) and 0.74 (0.70-0.78) for CRC, and 0.71 (0.65-0.77) and 0.74 (0.68-0.79) for rectal cancer, respectively. The NRI (95% CI) for a prediction model with GRS compared to the model with TRS alone was 0.17 (-0.05-0.37) for CRC and 0.41 (0.10-0.68) for rectal cancer alone.
Our results indicate genetic variants may be useful for predicting risk to CRC in the Koreans, especially risk for rectal cancer alone. Moreover, this study suggests effective prediction models for colon and rectal cancer should be developed separately.
全基因组关联研究已确定众多单核苷酸多态性(SNP)与欧洲血统人群的结直肠癌(CRC)风险相关。然而,它们在预测亚洲人患CRC风险方面的效用仍不明确。本研究使用了韩国癌症预防研究-II(KCPS-II)(N = 145,842)中的一项病例队列研究(随机子队列N = 1,685)。在KCPS-II子队列成员中对先前47项研究中确定的23个SNP进行了基因分型。通过对所有SNP的风险等位基因数量求和来计算遗传风险评分(GRS)。根据受试者工作特征曲线下面积(AUROC)和连续净重新分类指数(NRI)评估有无GRS的预测模型。
23个SNP中的7个与韩国人的CRC和直肠癌显著相关,但与单独的结肠癌无关。单独的传统风险评分(TRS)以及TRS加GRS的CRC的AUROCs(95% CI)分别为0.73(0.69 - 0.78)和0.74(0.70 - 0.78),直肠癌的分别为0.71(0.65 - 0.77)和0.74(0.68 - 0.79)。与仅使用TRS的模型相比,使用GRS的预测模型的CRC的NRI(95% CI)为0.17(-0.05 - 0.37),单独直肠癌的为0.41(0.10 - 0.68)。
我们的结果表明,基因变异可能有助于预测韩国人患CRC的风险,尤其是单独患直肠癌的风险。此外,本研究表明应分别开发针对结肠癌和直肠癌的有效预测模型。